Register your Account

Sign Up with us and Enjoy!
User nameEmailFirst NameLast NameContact info

A password will be e-mailed to you.

Notable News (PFE, FITB, PBR, ANR, RAD)


NEW YORK, January 2, 2013 , (MESHPRESS) – PennyStockParlay.com, an investment community with a  special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Pfizer Inc. (NYSE:PFE) shares climbed 1.86% to $25.55 in the early hour. Bristol-Myers Squibb Company and Pfizer Inc. on Dec. 28, announced that the U.S. Food and Drug Administration (FDA) has approved ELIQUIS (apixaban). Bristol-Myers Squibb and Pfizer will provide additional information on the FDA approval of Eliquis in a separate press release, to be issued next week.

Should Investors Buy PFE After The Recent Drop? Find Out Here

Fifth Third Bancorp (NASDAQ:FITB) shares gained 2.47% to $15.57. The company, last month, has announced an ex-dividend date of December 27, 2012 and a cash dividend payment of $0.1 per share scheduled for January 17, 2013. Shareholders who purchased FITB stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 25% increase over the same period a year ago.

We Have Free Trend Analysis on FITB, Find Out Here

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) stock increased 0.82% to $19.63. The company, on Dec. 19, announced that it has reached agreement for the acquisition of a 100% stake in Araucaria Nitrogenados SA from Vale SA. It is located in Araucaria, in the state of Parana in Brazil. The transaction value is BRL 234 million. Araucaria Nitrogenados SA has a production plant with the capacity of 700,000 tons per year of urea, 475 tons per year of ammonia and 450,000 cubic meters per year of Arla 32.

Get More latest News, Rumors and Updates On PBR Here

Alpha Natural Resources, Inc. (NYSE:ANR) shares fell 1.03% and closed at $9.64. Alpha Natural‘s stock had its “neutral” rating restated by equities researchers at Goldman Sachs in a report issued on Dec. 10.

Additionally, the company last released its earnings data on November 2. The company reported ($0.16) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.44) by $0.28. The company had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.68 billion.

How To Trade ANR Now After The Recent Volatile Moves? Find Out Here

Rite Aid Corporation (NYSE:RAD) stock gained 2.57% to $1.39. The company, prior last week, reported revenues of $6.2 billion, net income of $61.9 million, or $0.07 per diluted share, and Adjusted EBITDA of $295.3 million, or 4.7% of revenues. Same store sales for the quarter decreased 1.5% over the prior year 13-week period, consisting of a 1.1% increase in front end sales offset by a 2.7% decrease in pharmacy sales.

Don’t Forget To Get Your Free Trend Analysis Here

About PennyStockParlay.com
PennyStockParlay.com has been successful in bringing Stock Parlay members with top penny stock newsletter. Stock Parlay’s staff and penny stocks exploration methods have proved 100% accurate in finding the best penny stocks move in e-mail alerts. PennyStockParlay.com works all day and night to find the best penny stock picks portfolio through penny stock newsletter. PennyStockParlay.com has kept winning members with top penny stock newsletter.

Disclaimer:
The assembled information disseminated by PennyStockParlay.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. PennyStockParlay.com does expect that investors will buy and sell securities based on information assembled and presented in PennyStockParlay.com. Please always do due diligence; consult a financial advisor before buying or selling stocks.

Contact Information:
PennyStockParlay.com

Rich Smith
Tel: 2132610916

 

Related Press realease: